🔎 Trials Near Me

Home › Chronic Lymphocytic Leukemia › California › San Francisco

Chronic Lymphocytic Leukemia clinical trials in San Francisco, CA

4 studies for Chronic Lymphocytic Leukemia are looking for participants at sites in and around San Francisco (within about 30 miles). Open a study to see who can join and how to contact the study team.

A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

RecruitingPhase 3
  • Kaiser Permanente San Francisco Medical Center Oncology, San Francisco
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT06973187

A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies

RecruitingPhase 1
  • University of California, San Francisco, San Francisco
Ages 18 and older · All sexes · Updated Jul 2, 2026 · NCT05131022

Anti-CD19 Chimeric Antigen Receptor T Cells for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma

RecruitingPhase 1
  • University of California, San Francisco, San Francisco
Ages 18 and older · All sexes · Updated Jun 22, 2026 · NCT04545762

A Randomized Phase II Study Of Bruton Tyrosine Kinase Inhibitor With Or Without Venetoclax In Veterans With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

RecruitingPhase 2
  • San Francisco VA Medical Center, San Francisco, CA, San Francisco
Ages 18 to 80 · All sexes · Updated Oct 14, 2025 · NCT06520098

Chronic Lymphocytic Leukemia trials in other cities

Other studies in San Francisco

From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.